Publication:
Anti-proliferation and apoptosis induction in epidermoid carcinomaA431Cellsbyterminaliabelliricaextract

dc.contributor.authorInnajak S.
dc.contributor.authorChulasiri M.
dc.contributor.authorWatanapokasin R.
dc.date.accessioned2021-04-05T03:04:00Z
dc.date.available2021-04-05T03:04:00Z
dc.date.issued2019
dc.date.issuedBE2562
dc.description.abstractBackground: Squamous cell carcinoma (SCC) is a member of non-melanoma skin cancer (NMSC), which is slow-growing and high metastasis. UV exposed from the sun or tanning beds is one of the risk factors of SCC developing. Nowadays, SCC treatments include surgery, photodynamic therapy, radiation therapy and chemotherapy, but it is unsatisfactory. Therefore the finding of new therapeutic target is necessary. Objective: To investigate the effect of Terminalia bellirica extract on anti-proliferation and apoptosis induction in highly metastasis epidermoid carcinoma A431 cells. Materials and Methods: Cytotoxicity, cell viability and cell proliferation were determined by MTT assay. Nuclear morphological changes and protein expression were determined by Hoechst staining and Western blot analysis, respectively. Results: T. bellirica extract showed anti-proliferative effect on A431 cells. Hoechst staining revealed chromatin condensation and apoptotic bodies induction in A431 treated cells by T. bellirica extract. In addition, apoptosis induction via up-regulartion of Bax, Bik, and Bok as well as down-regulation of Mcl-1 was obtained. Moreover, T. bellirica extract showed apoptosis induction through caspase-7 protein activation. Conclusion: The present study showed that T. bellirica extract inhibited cell proliferation and induced apoptosis induction in A431 treated cells. The results indicated that T. bellirica extract may be further developed as skin cancer protection product. However the underlying mechanisms of apoptosis induction in A431 cells should be further studied. © JOURNAL OF THE MEDICAL ASSOCIATION OF Thailand| 2019
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 102, No.7 (2019)
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85074659549
dc.identifier.urihttps://hdl.handle.net/20.500.14740/5525
dc.rights.holderScopus
dc.subject.otherAntineoplastic agent
dc.subject.otherBcl2 interacting killer protein
dc.subject.otherBcl2 related ovarian killer protein
dc.subject.otherCaspase 7
dc.subject.otherPeptides and proteins
dc.subject.otherPlant extract
dc.subject.otherProtein Bax
dc.subject.otherProtein mcl 1
dc.subject.otherTerminalia bellirica extract
dc.subject.otherUnclassified drug
dc.subject.otherA-431 cell line
dc.subject.otherAntiproliferative activity
dc.subject.otherApoptosis
dc.subject.otherArticle
dc.subject.otherCell proliferation
dc.subject.otherCell structure
dc.subject.otherCell viability
dc.subject.otherChromatin condensation
dc.subject.otherControlled study
dc.subject.otherCytotoxicity
dc.subject.otherDown regulation
dc.subject.otherEnzyme activation
dc.subject.otherFluorescence microscopy
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherIC50
dc.subject.otherMTT assay
dc.subject.otherProtein expression
dc.subject.otherSquamous cell carcinoma
dc.subject.otherTerminalia bellirica
dc.subject.otherUpregulation
dc.subject.otherWestern blotting
dc.titleAnti-proliferation and apoptosis induction in epidermoid carcinomaA431Cellsbyterminaliabelliricaextract
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074659549&partnerID=40&md5=35f7b35e7905779277493007f2c51125

Files